Drug factory · FDA FEI 3006165229
MSN Pharmachem Private Limited
Plot No.: 182 to 186, 192-A, 193 to 197 & 212/ A, B, C, D, Phase-II IDA Pashamylaram, Pashamylaram (Village), Patancheru (Mandal), Sangareddy District, India
Problems found, fixed voluntarily at FDA's last inspection, Apr 21, 2023.
Voluntary Action Indicated: inspectors found problems, but not serious enough for FDA to take action. The company is expected to fix them.
4 drug inspections on record since 2011: 3 with no problems, 1 with problems fixed voluntarily, 0 with FDA action.
What it does, for whom
| Drug | Role | For | NDC |
|---|---|---|---|
| Aprepitant | Makes the active ingredient | Heron Therapeutics, Inc. | 47426-201 |
| Lacosamide | Makes the active ingredient | Hainan Poly Pharm. Co., Ltd. | 14335-330 |
FDA inspection history
| Ended | Result | Program | Problems noted |
|---|---|---|---|
| Apr 21, 2023 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
| May 18, 2018 | No problems found | Drug Quality Assurance | — |
| Jun 13, 2014 | No problems found | Drug Quality Assurance | — |
| Aug 5, 2011 | No problems found | Drug Quality Assurance | — |
Registered with FDA for: analysis; api manufacture.